We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.3B
AUM Growth
+$851M
(+4%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
1,274
New
347
Increased
260
Reduced
248
Closed
334
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 19.74% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Patria Investments
PAX
$1.77B
| $21.1M | 0.09% |
1,197,035
-1,217,087
| -50% | -$19.4M |
|
|
KDNY
277
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $21.1M | 0.09% |
1,492,900
+322,702
| +28% | +$5.16M |
|
278
Fortune Brands Innovations
FBIN
$5.88B
| $21M | 0.09% |
+246,285
| New | +$21.6M |
|
279
AT&T
T
$159B
| $20.9M | 0.09% |
+961,178
| New | +$21.9M |
|
|
TCDA
280
DELISTED
Tricida, Inc. Common Stock
TCDA
| $20.8M | 0.09% |
4,814,949
+2,160,588
| +81% | +$10.3M |
|
|
XM
281
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $20.8M | 0.09% |
+543,400
| New | +$19.1M |
|
282
Caterpillar
CAT
$373B
| $20.6M | 0.09% |
94,618
+7,465
| +9% | +$1.72M |
|
|
FITB
283
Fifth Third Bancorp
FITB
$51.3B
| $20.5M | 0.09% |
535,400
+414,300
| +342% | +$16.6M |
|
284
ResMed
RMD
$30.3B
| $20.3M | 0.09% |
+82,344
| New | +$17.3M |
|
285
Alnylam Pharmaceuticals
ALNY
$27.4B
| $20.3M | 0.09% |
119,689
-320,248
| -73% | -$46.9M |
|
286
Steris
STE
$22.5B
| $20.3M | 0.09% |
98,315
+23,287
| +31% | +$4.69M |
|
287
International Flavors & Fragrances
IFF
$20.3B
| $20.2M | 0.09% |
134,913
-61,445
| -31% | -$8.82M |
|
288
Travel + Leisure Co
TNL
$4.61B
| $20.1M | 0.09% |
337,500
-161,000
| -32% | -$10.2M |
|
289
AngioDynamics
ANGO
$610M
| $19.5M | 0.09% |
717,236
+286,427
| +66% | +$6.99M |
|
290
Enbridge
ENB
$121B
| $19.4M | 0.09% |
+484,233
| New | +$18.7M |
|
291
HCI Group
HCI
$2.32B
| $19.4M | 0.09% |
194,800
+19,744
| +11% | +$1.6M |
|
292
Flex
FLEX
$41B
| $19.2M | 0.09% |
1,428,781
-64,094
| -4% | -$871K |
|
|
293
Applied Materials
AMAT
$398B
| $19.2M | 0.09% |
134,601
-1,775,363
| -93% | -$238M |
|
294
Vulcan Materials
VMC
$35.2B
| $19M | 0.09% |
108,991
-67,045
| -38% | -$12M |
|
295
Marathon Petroleum
MPC
$91.7B
| $19M | 0.09% |
313,662
-348,373
| -53% | -$20.4M |
|
|
VZIO
296
DELISTED
VIZIO Holding Corp.
VZIO
| $18.8M | 0.08% |
696,564
+6,201
| +0.9% | +$146K |
|
|
RXDX
297
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $18.8M | 0.08% |
764,102
-35,898
| -4% | -$801K |
|
298
Sony
SONY
$134B
| $18.8M | 0.08% |
+965,000
| New | +$19.6M |
|
299
CALL
FirstEnergy
FE
$28.2B
| $18.6M | 0.08% |
+500,000
| New | +$18.6M |
|
300
New York Times
NYT
$12.3B
| $18.6M | 0.08% |
426,268
+17,723
| +4% | +$789K |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Point72 Asset Management held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Point72 Asset Management's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Point72 Asset Management's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Point72 Asset Management added most to Salesforce in Q2 2021, an estimated $372M increase.
- Point72 Asset Management's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Point72 Asset Management fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Point72 Asset Management's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Point72 Asset Management opened 347 new positions and closed 334 in Q2 2021.
- Point72 Asset Management's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.